Caplin Point Laboratories Limited

About Caplin Point Laboratories Limited

No company profile on record yet.

Key facts

BSE symbol524742

NSE symbolCAPLIPOINT

ISININE475E01026

CINL24231TN1990PLC019053

Listing date23 Jun 2014

Fiscal year end31 Mar

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

AuditorAlagar & Associates LLP (M. Alagar)

Registered officeAshvich Towers, 3rd Floor, No.3, Developed Plots, Industrial Estate

Registrar & transfer agentIntegrated Registry Management Services Private Limited 2nd Floor, Kences Towers, No.1, Ramakrishna Street, North Usman Road, T Nagar

Index memberships

NIFTY 500 NIFTY 500

Financial performance

Full financials →

Fiscal year	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Total income (before exceptional items)	922^†	887^†	731^†	628^†	585^†
Net profit	397	339	284	234	188^†

₹ Crore. ^† Summed from the four quarterly filings of that fiscal year.

Board of directors

Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.

Name	Designation	Term end
Sridhar Ganesan	Executive Director	June 30, 2026
K C John	Independent Director	June 30, 2026
R Nagendran	Independent Director	June 30, 2026
Ranganathan Vijayaraghavan	Independent Director	June 30, 2026
S Deenadayalan	Independent Director	June 30, 2026
Susan Mathew	Independent Director	June 30, 2026
Ashok Partheeban	Non-Executive Director	June 30, 2026
C C Paarthipan	Non-Executive Director	June 30, 2026
Vivek Partheeban	Non-Executive Director	June 30, 2026

Management, subsidiaries and brands

Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.